Reviews Diphtheria, Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B and Inactivated Poliovirus Vaccine


No reviews yet.

Pediarix Drug Description
PEDIARIX®
[Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, 
Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined]
DRUG DESCRIPTION



What are the possible side effects of this vaccine (Pediarix)?

Your child should not receive a booster vaccine if he or she had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects your child has after receiving this vaccine. When the child receives a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with diphtheria, hepatitis B, pertussis, polio, or tetanus is much more dangerous to your child's health than receiving the vaccine to protect against these...
Read All Potential Side Effects for Pediarix »




PEDIARIX® [Diphtheria and Tetanus Toxoids and Acellular
Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus
Vaccine Combined] is a noninfectious, sterile, multivalent vaccine for
intramuscular administration manufactured by GlaxoSmithKline Biologicals. It
contains diphtheria and tetanus toxoids, 3 pertussis antigens (inactivated
pertussis toxin [PT] and formaldehyde-treated filamentous hemagglutinin [FHA]
and pertactin [69 kiloDalton outer membrane protein]), hepatitis B surface
antigen, plus poliovirus Type 1 (Mahoney), Type 2 (MEF-1), and Type 3
(Saukett). The diphtheria toxoid, tetanus toxoid, and pertussis antigens are
the same as those in INFANRIX® (Diphtheria and Tetanus Toxoids and Acellular
Pertussis Vaccine Adsorbed). The hepatitis B surface antigen is the same as
that in ENGERIX-B® [Hepatitis B Vaccine (Recombinant)]. 
The diphtheria toxin is produced by growing Corynebacterium
diphtheriae in Fenton medium containing a bovineextract. Tetanus toxin is
produced by growing Clostridium tetani in a modified Latham medium
derived from bovine casein. The bovine materials used in these extracts are
sourced from countries which the United States Department of Agriculture (USDA)
has determined neither have nor are at risk of bovine spongiform encephalopathy
(BSE). Both toxins are detoxified with formaldehyde, concentrated by
ultrafiltration, and purified by precipitation, dialysis, and sterile
filtration. 
The 3 acellular pertussis antigens (PT, FHA, and pertactin)
are isolated from Bordetella pertussis culture grown in modified
Stainer-Scholte liquid medium. PT and FHA are isolated from the fermentation
broth; pertactin is extracted from the cells by heat treatment and
flocculation. The antigens are purified in successive chromatographic and
precipitation steps. PT is detoxified using glutaraldehyde and formaldehyde.
FHA and pertactin are treated with formaldehyde. 
The hepatitis B surface antigen (HBsAg) is obtained by
culturing genetically engineered Saccharomyces cerevisiae cells, which
carry the surface antigen gene of the hepatitis B virus, in synthetic medium.
The surface antigen expressed in the S. cerevisiae cells is purified by
several physiochemical steps, which include precipitation, ion exchange
chromatography, and ultrafiltration. 
The inactivated poliovirus component of PEDIARIX is an
enhanced potency component. Each of the 3 strains of poliovirus is individually
grown in VERO cells, a continuous line of monkey kidney cells, cultivated on
microcarriers. Calf serum and lactalbumin hydrolysate are used during VERO cell
culture and/or virus culture. Calf serum is sourced from countries the USDA has
determined neither have nor are at risk of BSE. After clarification, each viral
suspension is purified by ultrafiltration, diafiltration, and successive
chromatographic steps, and inactivated with formaldehyde. The 3 purified viral
strains are then pooled to form a trivalent concentrate. 
The diphtheria, tetanus, and pertussis antigens are
individually adsorbed onto aluminum hydroxide; hepatitis B component is
adsorbed onto aluminum phosphate. All antigens are then diluted and combined to
produce the final formulated vaccine. Each 0.5-mL dose is formulated to contain
25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated PT,
25 mcg of FHA, 8 mcg of pertactin, 10 mcg of HBsAg, 40 D-antigen Units (DU) of
Type 1 poliovirus, 8 DU of Type 2 poliovirus, and 32 DU of Type 3
poliovirus. 
Diphtheria and tetanus toxoid potency is determined by
measuring the amount of neutralizing antitoxin in previously immunized guinea
pigs. The potency of the acellular pertussis components (inactivated PT and
formaldehyde-treated FHA and pertactin) is determined by enzyme-linked
immunosorbent assay (ELISA) on sera from previously immunized mice. Potency of
the hepatitis B component is established by HBsAg ELISA. The potency of the
inactivated poliovirus component is determined by using the D-antigen ELISA and
by a poliovirus neutralizing cell culture assay on sera from previously
immunized rats. 
Each 0.5-mL dose also contains 4.5 mg of NaCl and aluminum
adjuvant (not more than 0.85 mg aluminum by assay). Each dose also contains
  ≤ 100 mcg of residual formaldehyde and ≤ 100 mcg of polysorbate
80 (Tween 80). Neomycin sulfate and polymyxin B are used in the polio vaccine
manufacturing process and may be present in the final vaccine at   ≤ 0.05
ng neomycin and  0.01 ng polymyxin B per dose. The procedures used to
manufacture the HBsAg antigen result in a product that contains ≤ 5% yeast
protein.  
PEDIARIX is formulated without preservatives. 
The vaccine must be well shaken before administration to
obtain a homogeneous, turbid, white suspension. 
Diphtheria and Tetanus Toxoids Adsorbed Combined Bulk (For
Further Manufacturing Use) is manufactured by Novartis Vaccines and Diagnostics
GmbH & Co. KG, Marburg, Germany. The acellular pertussis antigens, the
hepatitis B surface antigen, and the inactivated poliovirus antigens are
manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium. Formulation, filling, testing, packaging, and release of the vaccine are performed by
GlaxoSmithKline Biologicals.Last reviewed on RxList: 10/29/2009




Pediarix Drug Description
PEDIARIX®
[Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, 
Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined]
DRUG DESCRIPTION



What are the possible side effects of this vaccine (Pediarix)?

Your child should not receive a booster vaccine if he or she had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects your child has after receiving this vaccine. When the child receives a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with diphtheria, hepatitis B, pertussis, polio, or tetanus is much more dangerous to your child's health than receiving the vaccine to protect against these...
Read All Potential Side Effects for Pediarix »




PEDIARIX® [Diphtheria and Tetanus Toxoids and Acellular
Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus
Vaccine Combined] is a noninfectious, sterile, multivalent vaccine for
intramuscular administration manufactured by GlaxoSmithKline Biologicals. It
contains diphtheria and tetanus toxoids, 3 pertussis antigens (inactivated
pertussis toxin [PT] and formaldehyde-treated filamentous hemagglutinin [FHA]
and pertactin [69 kiloDalton outer membrane protein]), hepatitis B surface
antigen, plus poliovirus Type 1 (Mahoney), Type 2 (MEF-1), and Type 3
(Saukett). The diphtheria toxoid, tetanus toxoid, and pertussis antigens are
the same as those in INFANRIX® (Diphtheria and Tetanus Toxoids and Acellular
Pertussis Vaccine Adsorbed). The hepatitis B surface antigen is the same as
that in ENGERIX-B® [Hepatitis B Vaccine (Recombinant)]. 
The diphtheria toxin is produced by growing Corynebacterium
diphtheriae in Fenton medium containing a bovineextract. Tetanus toxin is
produced by growing Clostridium tetani in a modified Latham medium
derived from bovine casein. The bovine materials used in these extracts are
sourced from countries which the United States Department of Agriculture (USDA)
has determined neither have nor are at risk of bovine spongiform encephalopathy
(BSE). Both toxins are detoxified with formaldehyde, concentrated by
ultrafiltration, and purified by precipitation, dialysis, and sterile
filtration. 
The 3 acellular pertussis antigens (PT, FHA, and pertactin)
are isolated from Bordetella pertussis culture grown in modified
Stainer-Scholte liquid medium. PT and FHA are isolated from the fermentation
broth; pertactin is extracted from the cells by heat treatment and
flocculation. The antigens are purified in successive chromatographic and
precipitation steps. PT is detoxified using glutaraldehyde and formaldehyde.
FHA and pertactin are treated with formaldehyde. 
The hepatitis B surface antigen (HBsAg) is obtained by
culturing genetically engineered Saccharomyces cerevisiae cells, which
carry the surface antigen gene of the hepatitis B virus, in synthetic medium.
The surface antigen expressed in the S. cerevisiae cells is purified by
several physiochemical steps, which include precipitation, ion exchange
chromatography, and ultrafiltration. 
The inactivated poliovirus component of PEDIARIX is an
enhanced potency component. Each of the 3 strains of poliovirus is individually
grown in VERO cells, a continuous line of monkey kidney cells, cultivated on
microcarriers. Calf serum and lactalbumin hydrolysate are used during VERO cell
culture and/or virus culture. Calf serum is sourced from countries the USDA has
determined neither have nor are at risk of BSE. After clarification, each viral
suspension is purified by ultrafiltration, diafiltration, and successive
chromatographic steps, and inactivated with formaldehyde. The 3 purified viral
strains are then pooled to form a trivalent concentrate. 
The diphtheria, tetanus, and pertussis antigens are
individually adsorbed onto aluminum hydroxide; hepatitis B component is
adsorbed onto aluminum phosphate. All antigens are then diluted and combined to
produce the final formulated vaccine. Each 0.5-mL dose is formulated to contain
25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated PT,
25 mcg of FHA, 8 mcg of pertactin, 10 mcg of HBsAg, 40 D-antigen Units (DU) of
Type 1 poliovirus, 8 DU of Type 2 poliovirus, and 32 DU of Type 3
poliovirus. 
Diphtheria and tetanus toxoid potency is determined by
measuring the amount of neutralizing antitoxin in previously immunized guinea
pigs. The potency of the acellular pertussis components (inactivated PT and
formaldehyde-treated FHA and pertactin) is determined by enzyme-linked
immunosorbent assay (ELISA) on sera from previously immunized mice. Potency of
the hepatitis B component is established by HBsAg ELISA. The potency of the
inactivated poliovirus component is determined by using the D-antigen ELISA and
by a poliovirus neutralizing cell culture assay on sera from previously
immunized rats. 
Each 0.5-mL dose also contains 4.5 mg of NaCl and aluminum
adjuvant (not more than 0.85 mg aluminum by assay). Each dose also contains
  ≤ 100 mcg of residual formaldehyde and ≤ 100 mcg of polysorbate
80 (Tween 80). Neomycin sulfate and polymyxin B are used in the polio vaccine
manufacturing process and may be present in the final vaccine at   ≤ 0.05
ng neomycin and  0.01 ng polymyxin B per dose. The procedures used to
manufacture the HBsAg antigen result in a product that contains ≤ 5% yeast
protein.  
PEDIARIX is formulated without preservatives. 
The vaccine must be well shaken before administration to
obtain a homogeneous, turbid, white suspension. 
Diphtheria and Tetanus Toxoids Adsorbed Combined Bulk (For
Further Manufacturing Use) is manufactured by Novartis Vaccines and Diagnostics
GmbH & Co. KG, Marburg, Germany. The acellular pertussis antigens, the
hepatitis B surface antigen, and the inactivated poliovirus antigens are
manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium. Formulation, filling, testing, packaging, and release of the vaccine are performed by
GlaxoSmithKline Biologicals.Last reviewed on RxList: 10/29/2009




Pediarix Drug Description
PEDIARIX®
[Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, 
Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined]
DRUG DESCRIPTION



What are the possible side effects of this vaccine (Pediarix)?

Your child should not receive a booster vaccine if he or she had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects your child has after receiving this vaccine. When the child receives a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with diphtheria, hepatitis B, pertussis, polio, or tetanus is much more dangerous to your child's health than receiving the vaccine to protect against these...
Read All Potential Side Effects for Pediarix »




PEDIARIX® [Diphtheria and Tetanus Toxoids and Acellular
Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus
Vaccine Combined] is a noninfectious, sterile, multivalent vaccine for
intramuscular administration manufactured by GlaxoSmithKline Biologicals. It
contains diphtheria and tetanus toxoids, 3 pertussis antigens (inactivated
pertussis toxin [PT] and formaldehyde-treated filamentous hemagglutinin [FHA]
and pertactin [69 kiloDalton outer membrane protein]), hepatitis B surface
antigen, plus poliovirus Type 1 (Mahoney), Type 2 (MEF-1), and Type 3
(Saukett). The diphtheria toxoid, tetanus toxoid, and pertussis antigens are
the same as those in INFANRIX® (Diphtheria and Tetanus Toxoids and Acellular
Pertussis Vaccine Adsorbed). The hepatitis B surface antigen is the same as
that in ENGERIX-B® [Hepatitis B Vaccine (Recombinant)]. 
The diphtheria toxin is produced by growing Corynebacterium
diphtheriae in Fenton medium containing a bovineextract. Tetanus toxin is
produced by growing Clostridium tetani in a modified Latham medium
derived from bovine casein. The bovine materials used in these extracts are
sourced from countries which the United States Department of Agriculture (USDA)
has determined neither have nor are at risk of bovine spongiform encephalopathy
(BSE). Both toxins are detoxified with formaldehyde, concentrated by
ultrafiltration, and purified by precipitation, dialysis, and sterile
filtration. 
The 3 acellular pertussis antigens (PT, FHA, and pertactin)
are isolated from Bordetella pertussis culture grown in modified
Stainer-Scholte liquid medium. PT and FHA are isolated from the fermentation
broth; pertactin is extracted from the cells by heat treatment and
flocculation. The antigens are purified in successive chromatographic and
precipitation steps. PT is detoxified using glutaraldehyde and formaldehyde.
FHA and pertactin are treated with formaldehyde. 
The hepatitis B surface antigen (HBsAg) is obtained by
culturing genetically engineered Saccharomyces cerevisiae cells, which
carry the surface antigen gene of the hepatitis B virus, in synthetic medium.
The surface antigen expressed in the S. cerevisiae cells is purified by
several physiochemical steps, which include precipitation, ion exchange
chromatography, and ultrafiltration. 
The inactivated poliovirus component of PEDIARIX is an
enhanced potency component. Each of the 3 strains of poliovirus is individually
grown in VERO cells, a continuous line of monkey kidney cells, cultivated on
microcarriers. Calf serum and lactalbumin hydrolysate are used during VERO cell
culture and/or virus culture. Calf serum is sourced from countries the USDA has
determined neither have nor are at risk of BSE. After clarification, each viral
suspension is purified by ultrafiltration, diafiltration, and successive
chromatographic steps, and inactivated with formaldehyde. The 3 purified viral
strains are then pooled to form a trivalent concentrate. 
The diphtheria, tetanus, and pertussis antigens are
individually adsorbed onto aluminum hydroxide; hepatitis B component is
adsorbed onto aluminum phosphate. All antigens are then diluted and combined to
produce the final formulated vaccine. Each 0.5-mL dose is formulated to contain
25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated PT,
25 mcg of FHA, 8 mcg of pertactin, 10 mcg of HBsAg, 40 D-antigen Units (DU) of
Type 1 poliovirus, 8 DU of Type 2 poliovirus, and 32 DU of Type 3
poliovirus. 
Diphtheria and tetanus toxoid potency is determined by
measuring the amount of neutralizing antitoxin in previously immunized guinea
pigs. The potency of the acellular pertussis components (inactivated PT and
formaldehyde-treated FHA and pertactin) is determined by enzyme-linked
immunosorbent assay (ELISA) on sera from previously immunized mice. Potency of
the hepatitis B component is established by HBsAg ELISA. The potency of the
inactivated poliovirus component is determined by using the D-antigen ELISA and
by a poliovirus neutralizing cell culture assay on sera from previously
immunized rats. 
Each 0.5-mL dose also contains 4.5 mg of NaCl and aluminum
adjuvant (not more than 0.85 mg aluminum by assay). Each dose also contains
  ≤ 100 mcg of residual formaldehyde and ≤ 100 mcg of polysorbate
80 (Tween 80). Neomycin sulfate and polymyxin B are used in the polio vaccine
manufacturing process and may be present in the final vaccine at   ≤ 0.05
ng neomycin and  0.01 ng polymyxin B per dose. The procedures used to
manufacture the HBsAg antigen result in a product that contains ≤ 5% yeast
protein.  
PEDIARIX is formulated without preservatives. 
The vaccine must be well shaken before administration to
obtain a homogeneous, turbid, white suspension. 
Diphtheria and Tetanus Toxoids Adsorbed Combined Bulk (For
Further Manufacturing Use) is manufactured by Novartis Vaccines and Diagnostics
GmbH & Co. KG, Marburg, Germany. The acellular pertussis antigens, the
hepatitis B surface antigen, and the inactivated poliovirus antigens are
manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium. Formulation, filling, testing, packaging, and release of the vaccine are performed by
GlaxoSmithKline Biologicals.Last reviewed on RxList: 10/29/2009




Pediarix Drug Description
PEDIARIX®
[Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, 
Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined]
DRUG DESCRIPTION



What are the possible side effects of this vaccine (Pediarix)?

Your child should not receive a booster vaccine if he or she had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects your child has after receiving this vaccine. When the child receives a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with diphtheria, hepatitis B, pertussis, polio, or tetanus is much more dangerous to your child's health than receiving the vaccine to protect against these...
Read All Potential Side Effects for Pediarix »




PEDIARIX® [Diphtheria and Tetanus Toxoids and Acellular
Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus
Vaccine Combined] is a noninfectious, sterile, multivalent vaccine for
intramuscular administration manufactured by GlaxoSmithKline Biologicals. It
contains diphtheria and tetanus toxoids, 3 pertussis antigens (inactivated
pertussis toxin [PT] and formaldehyde-treated filamentous hemagglutinin [FHA]
and pertactin [69 kiloDalton outer membrane protein]), hepatitis B surface
antigen, plus poliovirus Type 1 (Mahoney), Type 2 (MEF-1), and Type 3
(Saukett). The diphtheria toxoid, tetanus toxoid, and pertussis antigens are
the same as those in INFANRIX® (Diphtheria and Tetanus Toxoids and Acellular
Pertussis Vaccine Adsorbed). The hepatitis B surface antigen is the same as
that in ENGERIX-B® [Hepatitis B Vaccine (Recombinant)]. 
The diphtheria toxin is produced by growing Corynebacterium
diphtheriae in Fenton medium containing a bovineextract. Tetanus toxin is
produced by growing Clostridium tetani in a modified Latham medium
derived from bovine casein. The bovine materials used in these extracts are
sourced from countries which the United States Department of Agriculture (USDA)
has determined neither have nor are at risk of bovine spongiform encephalopathy
(BSE). Both toxins are detoxified with formaldehyde, concentrated by
ultrafiltration, and purified by precipitation, dialysis, and sterile
filtration. 
The 3 acellular pertussis antigens (PT, FHA, and pertactin)
are isolated from Bordetella pertussis culture grown in modified
Stainer-Scholte liquid medium. PT and FHA are isolated from the fermentation
broth; pertactin is extracted from the cells by heat treatment and
flocculation. The antigens are purified in successive chromatographic and
precipitation steps. PT is detoxified using glutaraldehyde and formaldehyde.
FHA and pertactin are treated with formaldehyde. 
The hepatitis B surface antigen (HBsAg) is obtained by
culturing genetically engineered Saccharomyces cerevisiae cells, which
carry the surface antigen gene of the hepatitis B virus, in synthetic medium.
The surface antigen expressed in the S. cerevisiae cells is purified by
several physiochemical steps, which include precipitation, ion exchange
chromatography, and ultrafiltration. 
The inactivated poliovirus component of PEDIARIX is an
enhanced potency component. Each of the 3 strains of poliovirus is individually
grown in VERO cells, a continuous line of monkey kidney cells, cultivated on
microcarriers. Calf serum and lactalbumin hydrolysate are used during VERO cell
culture and/or virus culture. Calf serum is sourced from countries the USDA has
determined neither have nor are at risk of BSE. After clarification, each viral
suspension is purified by ultrafiltration, diafiltration, and successive
chromatographic steps, and inactivated with formaldehyde. The 3 purified viral
strains are then pooled to form a trivalent concentrate. 
The diphtheria, tetanus, and pertussis antigens are
individually adsorbed onto aluminum hydroxide; hepatitis B component is
adsorbed onto aluminum phosphate. All antigens are then diluted and combined to
produce the final formulated vaccine. Each 0.5-mL dose is formulated to contain
25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated PT,
25 mcg of FHA, 8 mcg of pertactin, 10 mcg of HBsAg, 40 D-antigen Units (DU) of
Type 1 poliovirus, 8 DU of Type 2 poliovirus, and 32 DU of Type 3
poliovirus. 
Diphtheria and tetanus toxoid potency is determined by
measuring the amount of neutralizing antitoxin in previously immunized guinea
pigs. The potency of the acellular pertussis components (inactivated PT and
formaldehyde-treated FHA and pertactin) is determined by enzyme-linked
immunosorbent assay (ELISA) on sera from previously immunized mice. Potency of
the hepatitis B component is established by HBsAg ELISA. The potency of the
inactivated poliovirus component is determined by using the D-antigen ELISA and
by a poliovirus neutralizing cell culture assay on sera from previously
immunized rats. 
Each 0.5-mL dose also contains 4.5 mg of NaCl and aluminum
adjuvant (not more than 0.85 mg aluminum by assay). Each dose also contains
  ≤ 100 mcg of residual formaldehyde and ≤ 100 mcg of polysorbate
80 (Tween 80). Neomycin sulfate and polymyxin B are used in the polio vaccine
manufacturing process and may be present in the final vaccine at   ≤ 0.05
ng neomycin and  0.01 ng polymyxin B per dose. The procedures used to
manufacture the HBsAg antigen result in a product that contains ≤ 5% yeast
protein.  
PEDIARIX is formulated without preservatives. 
The vaccine must be well shaken before administration to
obtain a homogeneous, turbid, white suspension. 
Diphtheria and Tetanus Toxoids Adsorbed Combined Bulk (For
Further Manufacturing Use) is manufactured by Novartis Vaccines and Diagnostics
GmbH & Co. KG, Marburg, Germany. The acellular pertussis antigens, the
hepatitis B surface antigen, and the inactivated poliovirus antigens are
manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium. Formulation, filling, testing, packaging, and release of the vaccine are performed by
GlaxoSmithKline Biologicals.Last reviewed on RxList: 10/29/2009




Pediarix Drug Description
PEDIARIX®
[Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, 
Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined]
DRUG DESCRIPTION



What are the possible side effects of this vaccine (Pediarix)?

Your child should not receive a booster vaccine if he or she had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects your child has after receiving this vaccine. When the child receives a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with diphtheria, hepatitis B, pertussis, polio, or tetanus is much more dangerous to your child's health than receiving the vaccine to protect against these...
Read All Potential Side Effects for Pediarix »




PEDIARIX® [Diphtheria and Tetanus Toxoids and Acellular
Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus
Vaccine Combined] is a noninfectious, sterile, multivalent vaccine for
intramuscular administration manufactured by GlaxoSmithKline Biologicals. It
contains diphtheria and tetanus toxoids, 3 pertussis antigens (inactivated
pertussis toxin [PT] and formaldehyde-treated filamentous hemagglutinin [FHA]
and pertactin [69 kiloDalton outer membrane protein]), hepatitis B surface
antigen, plus poliovirus Type 1 (Mahoney), Type 2 (MEF-1), and Type 3
(Saukett). The diphtheria toxoid, tetanus toxoid, and pertussis antigens are
the same as those in INFANRIX® (Diphtheria and Tetanus Toxoids and Acellular
Pertussis Vaccine Adsorbed). The hepatitis B surface antigen is the same as
that in ENGERIX-B® [Hepatitis B Vaccine (Recombinant)]. 
The diphtheria toxin is produced by growing Corynebacterium
diphtheriae in Fenton medium containing a bovineextract. Tetanus toxin is
produced by growing Clostridium tetani in a modified Latham medium
derived from bovine casein. The bovine materials used in these extracts are
sourced from countries which the United States Department of Agriculture (USDA)
has determined neither have nor are at risk of bovine spongiform encephalopathy
(BSE). Both toxins are detoxified with formaldehyde, concentrated by
ultrafiltration, and purified by precipitation, dialysis, and sterile
filtration. 
The 3 acellular pertussis antigens (PT, FHA, and pertactin)
are isolated from Bordetella pertussis culture grown in modified
Stainer-Scholte liquid medium. PT and FHA are isolated from the fermentation
broth; pertactin is extracted from the cells by heat treatment and
flocculation. The antigens are purified in successive chromatographic and
precipitation steps. PT is detoxified using glutaraldehyde and formaldehyde.
FHA and pertactin are treated with formaldehyde. 
The hepatitis B surface antigen (HBsAg) is obtained by
culturing genetically engineered Saccharomyces cerevisiae cells, which
carry the surface antigen gene of the hepatitis B virus, in synthetic medium.
The surface antigen expressed in the S. cerevisiae cells is purified by
several physiochemical steps, which include precipitation, ion exchange
chromatography, and ultrafiltration. 
The inactivated poliovirus component of PEDIARIX is an
enhanced potency component. Each of the 3 strains of poliovirus is individually
grown in VERO cells, a continuous line of monkey kidney cells, cultivated on
microcarriers. Calf serum and lactalbumin hydrolysate are used during VERO cell
culture and/or virus culture. Calf serum is sourced from countries the USDA has
determined neither have nor are at risk of BSE. After clarification, each viral
suspension is purified by ultrafiltration, diafiltration, and successive
chromatographic steps, and inactivated with formaldehyde. The 3 purified viral
strains are then pooled to form a trivalent concentrate. 
The diphtheria, tetanus, and pertussis antigens are
individually adsorbed onto aluminum hydroxide; hepatitis B component is
adsorbed onto aluminum phosphate. All antigens are then diluted and combined to
produce the final formulated vaccine. Each 0.5-mL dose is formulated to contain
25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated PT,
25 mcg of FHA, 8 mcg of pertactin, 10 mcg of HBsAg, 40 D-antigen Units (DU) of
Type 1 poliovirus, 8 DU of Type 2 poliovirus, and 32 DU of Type 3
poliovirus. 
Diphtheria and tetanus toxoid potency is determined by
measuring the amount of neutralizing antitoxin in previously immunized guinea
pigs. The potency of the acellular pertussis components (inactivated PT and
formaldehyde-treated FHA and pertactin) is determined by enzyme-linked
immunosorbent assay (ELISA) on sera from previously immunized mice. Potency of
the hepatitis B component is established by HBsAg ELISA. The potency of the
inactivated poliovirus component is determined by using the D-antigen ELISA and
by a poliovirus neutralizing cell culture assay on sera from previously
immunized rats. 
Each 0.5-mL dose also contains 4.5 mg of NaCl and aluminum
adjuvant (not more than 0.85 mg aluminum by assay). Each dose also contains
  ≤ 100 mcg of residual formaldehyde and ≤ 100 mcg of polysorbate
80 (Tween 80). Neomycin sulfate and polymyxin B are used in the polio vaccine
manufacturing process and may be present in the final vaccine at   ≤ 0.05
ng neomycin and  0.01 ng polymyxin B per dose. The procedures used to
manufacture the HBsAg antigen result in a product that contains ≤ 5% yeast
protein.  
PEDIARIX is formulated without preservatives. 
The vaccine must be well shaken before administration to
obtain a homogeneous, turbid, white suspension. 
Diphtheria and Tetanus Toxoids Adsorbed Combined Bulk (For
Further Manufacturing Use) is manufactured by Novartis Vaccines and Diagnostics
GmbH & Co. KG, Marburg, Germany. The acellular pertussis antigens, the
hepatitis B surface antigen, and the inactivated poliovirus antigens are
manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium. Formulation, filling, testing, packaging, and release of the vaccine are performed by
GlaxoSmithKline Biologicals.Last reviewed on RxList: 10/29/2009





Other reviews about Diphtheria, Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B and Inactivated Poliovirus Vaccine on wordpress

VACCINATION INGREDIENTS
  by vanessashibley
imagine a person comes into your childs class, home ect.  and says I have a needle filled with aborted fetus tissue, alumium, mercury, antifreeze, milk and bacteria and […]


Vaccination Ingredients.....YOU NEED TO LOOK AT THIS
  by vanessashibley
Imagine a person comes into your childs class, home ect.  and says I have a needle filled with aborted fetus tissue, alumium, mercury, antifreeze, milk and bacteria and […]


Vaccines: Are They Vegan?
  by vivisectionexposed
  Vaccines Exposed Vaccines are a branch of pharmaceutical products which we have come to see as common place in our society for at least 200 years (even though their […]


Medicine, medical doctors, health care, formaldehyde in birth control pills and vaccines, thimerisol continues to be in flu vaccines given to children and pregnant women and elderly, aluminum is being injected into people with every vaccination and in many injected drugs, truth, honesty and health care reform - Any medical doctor, health care professional, nurse or surgeon with a prescription pad making out a prescription for any of us would only be truthful and honest, if he or she actually said this to us when making out that prescription -
  by cricketdiane
The honest, truthful representation of medicine and health care in America - Any medical doctor, health care professional, nurse or surgeon with a prescription pad making out a prescription […]


Ingredients in the Swine Flu H1N1 Vaccine; Resources, Risks and Dangers
  by yellowstaressentials
READ the full published Associated Content Article here A trusted friend of mine who happens to work for a chiropractor sent me an email that disturbed me and piqued […]


GlaxoSmithKline - Products
  by El Horror
About - Every second: Distributes more than 35 doses of vaccine. - Every minute: More than 1,100 prescriptions are written for GSK products. - Every hour: Spends more than $562,000 to […]


Guest Commentary - Is the Government Murdering Us?
  by USWeapon
Alrighty, I know that the title above already has a few people shaking their head yes and a few other people shaking their head no and yet another […]


GlaxoSmithKline - Vaccines (2009)
  by El Horror
About - ACWY Vax: Meningococcal polysaccharides serogroups A, C, W135 and Y. - Ambirix: Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed). - Arepanrix: AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine. - […]


Vaccines Who Makes Them, and What’s In Them?
  by Alphabiotics
March 30, 2009 The following is a description of the various chemical compounds added to vaccines for stability and other marketing purposes that have nothing to do […]



Other reviews about Diphtheria, Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B and Inactivated Poliovirus Vaccine on web:

Diphtheria and Tetanus Toxoids, Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Inactivated Poliovirus Vaccine Combined professional patient advice. Specific and up to ... Complete Diphtheria and Tetanus Toxoids, Acellular Pertussis ...


Learn about the prescription medication Pediarix (Diphtheria, Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B and Inactivated Poliovirus Vaccine), drug uses ... Pediarix (Diphtheria, Tetanus Toxoids and Acellular Pertussis ...


Resources for You. Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined Pediarix


Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B and inactivated poliovirus vaccine: DTaP-HepB-IPV: Pediarix: Diphtheria and tetanus toxoids and acellular ... Vaccines: ACIP/Meetings, Agendas, Dates, Registration/vac-abbrev


PEDIARIX  [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined] Diphtheria and Tetanus ... Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed ...


... DTaP) vaccinations have been with PEDIARIX [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined ... FDA Approves Kinrix - New Combination Vaccine for Children


... FDA) licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), hepatitis B (HepB) (recombinant) and inactivated poliovirus vaccine (IPV), DTaP ... Notice to Readers: FDA Licensure of Diphtheria and Tetanus Toxoids ...


Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vac... PEDIARIX® [Diphtheria and Tetanus Toxoids and Acellular Pertussis ...


PEDIARIX [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine] Suspension for Intramuscular Injection Initial ... diphtheria and tetanus toxoids and acellular pertussis adsorbed ...


Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined - Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed ...





Featured Reviews

Reviews Ketorolac Tromethamine Nasal Spray

Sprix Drug Description SPRIX™ (ketorolac tromethamine) Nasal Spray WARNING LIMITATIONS OF USE, GASTROINTESTINAL, BLEEDING, CARDIOVASCULAR, and RENAL RISK Limitations of Use SPRIX (ketorolac tromethamine), a nonsteroidal anti-inflammatory...
Read More  |  Review This
Reviews Ethyol

Ethyol Drug Description ETHYOL® (amifostine) for Injection DRUG DESCRIPTION ETHYOL (amifostine) is an organic thiophosphate cytoprotective agent known chemically as 2-[(3-aminopropyl)amino]ethanethiol dihydrogen phosphate (ester) ...
Read More  |  Review This
Reviews Factor IX Complex

Konyne Drug Description DRUG DESCRIPTION What are the possible side effects of factor IX complex? Factor IX complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause...
Read More  |  Review This
Reviews Pulmicort Turbuhaler

Pulmicort Turbuhaler Drug Description PULMICORT TURBUHALER® (budesonide) Inhalation Powder 200 mcg For Oral Inhalation Only. DRUG DESCRIPTION Budesonide, the active component of PULMICORT TURBUHALER 200 mcg, is a corticosteroid ...
Read More  |  Review This
Reviews Flovent

Flovent Drug Description FLOVENT® 44 mcg
(fluticasone propionate, 44 mcg) Inhalation Aerosol FLOVENT® 110 mcg (fluticasone propionate, 110 mcg) Inhalation Aerosol FLOVENT® 220 mcg (fluticasone propionate, 220 mcg)...

Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....